Bank of Montreal vs Cassava Sciences Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Bank of Montreal is far larger — about 2656.1× Cassava Sciences Inc's market cap, and Bank of Montreal pays a 2.69% dividend while Cassava Sciences Inc pays none. Which is the better fit depends on your goals.
| BMO | FLNA | |
|---|---|---|
Market Cap | $126.83B | $47.75M |
Sector | Financials | Health |
52-Week High | $183.65 | $4.64 |
52-Week Low | $112.54 | $0.87 |
Dividend Yield | 2.69% | — |
Enterprise Value | — | -$34.93M |
Trailing returns across standard periods
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →